×
Please click
here
if you are not redirected within a few seconds.
All
News
Images
Videos
Maps
Shopping
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
Sernova Seeks Cash And A Partner To Move Type 1 Diabetes Cell Therapy Forward
Scrip
The company's CEO Cynthia Pussinen joined the company last year and talked to Scrip about her plans to advance a cell therapy for type 1 diabetes.
2 days ago
Sernova Corp. AGM Elects Board, Advances Therapies - TipRanks.com
Tipranks
Sernova Corp (TSE:SVA) has released an update. Sernova Corp. recently held its Annual General Meeting (AGM), reporting the election of new...
3 days ago
Sernova (TSE:SVA) Shares Down 5.8%
Defense World
Sernova Corp. (TSE:SVA – Get Free Report)'s share price traded down 5.8% on Thursday . The company traded as low as C$0.40 and last traded...
1 day ago
Sernova reports positive interim data for Cell Pouch System
Drug Delivery Business
Sernova today announced positive interim data from the clinical trial of its Cell Pouch System in patients with type 1 diabetes.
10 months ago
Sernova Announces Positive Ongoing Interim Phase 1/2 Clinical Data for the Cell Pouch System™ for Type 1 Diabetes ...
GlobeNewswire
Sernova Announces Positive Ongoing Interim Phase 1/2 Clinical Data for the Cell Pouch System™ for Type 1 Diabetes Trial at the 2023 IPITA, IXA,...
6 months ago
Women in Science: Cynthia Pussinen, CEO of Sernova on how her career was 'written in the stars'
biopharma-reporter.com
Cynthia Pussinen knew she wanted to work in STEM fields by the time she was a teenager, she received a full scholarship to study nuclear...
5 months ago
Sernova Names Nicholas Rossettos Interim CFO
MarketWatch
By Robb M. Stewart Sernova said Monday Nicholas Rossettos has joined the biotechnology company on a consulting basis as interim chief...
1 month ago
Sernova to Participate in Biotech Showcase(TM) 2015 Healthcare Conference in San Francisco
Yahoo News Singapore
Sernova Corp , announced today that Dr. Philip Toleikis, Ph.D., president and CEO will be participating in the Biotech Showcase healthcare...
1 week ago
Endpoints News — #1809- Sernova, CellTrans bet big on type 1; Madrigal's $500M offering ahead of NASH decision
Endpoints News
The drug could become the first commercially available treatment for NASH. Aside from the launch, the money could be used for R&D work, clinical...
7 months ago
FDA awards support work into Cell Pouch System for hemophilia A
Hemophilia News Today
FDA awards support Sernova's work into Cell Pouch for hemophilia A · Gene therapy for hemophilia A reduces bleeding in clinical trial · Cell...
5 months ago